Latest Period
Q1 2026
Security Snapshot
Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE) Institutional Ownership
CUSIP: 922967104
13F Institutional Holders and Ownership History for Q1 2026
Institutions Reporting
80
Shares (Excl. Options)
25,966,156
Price
$63.15
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Symbol
- MANE on NYSE
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 25,966,156
- Total 13F value
- $1,637,524,019
- Portfolio coverage rank
- 0.01%
- Share change
- +25,056,398
- Value change
- +$1,580,072,801
- Number of holders
- 80
- Shares outstanding
- 37,567,889
- SEC-reported price per share
- $103.90
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- MANE - Veradermics, Inc - Common Stock, par value $0.00001 per share is tracked under CUSIP 922967104.
- 80 institutions reported positions in Q1 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Latest quarter on this page is Q1 2026.
- Additional quarter-over-quarter change detail appears as history expands.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 80 institutions filings for Q1 2026.
Security key
922967104
Latest holder period
Q1 2026
13F holders
80
13D/G owners
6
CIK / CUSIP context first
Open Q1 2026 holders
MANE full holder history
Veradermics, Inc SEC filings
Veradermics, Inc company facts
Veradermics, Inc insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 922967104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
MANE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Longitude Capital Partners V, LLC | 11% | -9.2% | $320,186,462 | 4,653,873 | 0% | Patrick G. Enright | 01 May 2026 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 9.9% | -17% | $287,041,925 | +$215,344 | 4,172,121 | +0.08% | SUVRETTA CAPITAL MANAGEMENT, LLC | 01 May 2026 |
| SR ONE CAPITAL MANAGEMENT, LLC | 6.4% | 2,401,868 | SR One Capital Management, LLC | 05 Feb 2026 | ||||
| CITADEL ADVISORS LLC | 4.5% | $128,710,490 | 1,870,792 | Kenneth Griffin | 30 Apr 2026 | |||
| VIKING GLOBAL INVESTORS LP | 4.5% | -22% | $116,310,184 | -$31,712,534 | 1,690,555 | -21% | VIKING GLOBAL INVESTORS LP | 31 Mar 2026 |
| Seven Fleet Capital Management LP | 0.2% | $5,504,000 | 80,000 | Seven Fleet Capital Management LP | 01 May 2026 |
As of 31 Mar 2026, 80 institutional investors reported holding 25,966,156 shares of Veradermics, Inc - Common Stock, par value $0.00001 per share (MANE). This represents 69% of the company’s total 37,567,889 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11% | 4,168,970 | 7.1% | $263,270,456 | |
| SR One Capital Management, LP | 6.4% | 2,401,868 | 17% | $151,677,964 | |
| CITADEL ADVISORS LLC | 4.9% | 1,825,672 | 0.08% | $115,291,187 | |
| FMR LLC | 4.8% | 1,792,909 | 0.01% | $113,222,208 | |
| VIKING GLOBAL INVESTORS LP | 4.5% | 1,690,555 | 0.3% | $106,758,548 | |
| Siren, L.L.C. | 4% | 1,505,374 | 2.6% | $95,064,368 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2.9% | 1,100,000 | 0.11% | $69,465,000 | |
| Aberdeen Group plc | 2.8% | 1,054,660 | 0.11% | $66,601,779 | |
| JPMORGAN CHASE & CO | 2.6% | 976,166 | 0% | $59,399,700 | |
| INFINITUM ASSET MANAGEMENT, LLC | 1.9% | 731,149 | 5.8% | $46,172,059 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9% | 699,645 | 0% | 0% | $44,182,582 |
| MARSHALL WACE, LLP | 1.7% | 654,601 | 0.04% | $41,338,053 | |
| Balyasny Asset Management L.P. | 1.4% | 532,906 | 0.07% | $33,653,014 | |
| Paradigm Biocapital Advisors LP | 1.4% | 525,000 | 0.68% | $33,153,750 | |
| AMERIPRISE FINANCIAL INC | 1.4% | 514,035 | 0.01% | $32,461,444 | |
| Woodline Partners LP | 1.3% | 500,646 | 0.12% | $31,615,795 | |
| Deep Track Capital, LP | 1.3% | 500,000 | 0.65% | $31,575,000 | |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3% | 477,833 | 0.01% | $30,175,154 | |
| UBS Group AG | 0.92% | 347,075 | 0% | $21,917,786 | |
| Vivo Capital, LLC | 0.8% | 300,000 | 1.6% | $18,945,000 | |
| STIFEL FINANCIAL CORP | 0.78% | 294,117 | 0.02% | $18,573,489 | |
| BlackRock, Inc. | 0.75% | 282,611 | 0% | $17,846,885 | |
| FRANKLIN RESOURCES INC | 0.53% | 200,000 | 0% | $12,630,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.47% | 178,206 | 0% | $11,260,302 | |
| Catalio Capital Management, LP | 0.46% | 173,582 | 2.3% | $10,961,703 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
1
Latest
Q1 2026
Rows shown
1-1 of 1
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 25,966,156 | $1,637,524,019 | +$1,580,072,801 | $63.15 | 80 |